A Delicate Balance of Innovation and Access: The Future of Gene Patenting

This event will discuss in depth the science involved in the Myriad decision, the decision's holding, its implications for industry, and its likely impact on genetic testing in clinical care. Panelists include scientists, lawyers, genetic counselors, and patient advocates. Don't miss it!